Penile traction therapy for treatment of Peyronie's disease

Penile traction therapy for treatment of Peyronie’s disease: a single-center pilot study - PubMed

Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study.

INTRODUCTION: Peyronie’s disease (PD) is a fibrotic disorder of the penis whose etiopathophysiology remains unclear. At this time, there is no known reliable nonsurgical treatment. This study reviews our experience with external penile traction therapy to correct the deformity associated with this disorder. AIM: To evaluate prolonged external penile traction as a nonsurgical treatment for PD. METHODS: Ten men with PD completed this noncontrolled pilot study of traction therapy using the FastSize Penile Extender. Nearly all (90%) had failed prior medical therapy. Traction was applied as the only treatment for 2-8 hours/day for 6 months. All subjects underwent pre- and post-treatment physical examination including measurement of stretched flaccid penile length (SPL) and biothesiometry. MAIN OUTCOME MEASURES: Curvature and girth were measured during erection before and after treatment with dynamic duplex ultrasound. Assessment of erectile and sexual function was further assessed with the International Index of Erectile Function and Quality of Life Specific to Male Erection Difficulties (QOL-MED) questionnaires. At 3 and 6 months post-treatment, SPL was measured and subjective assessment of deformity by the patient was recorded. RESULTS: Subjectively all men noted reduced curvature estimated at 10-40 degrees, increased penile length (1-2.5 cm) and enhanced girth in areas of indentation or narrowing. Objective measures demonstrated reduced curvature in all men from 10-45 degrees; average reduction for the group was 33% (51-34 degrees). SPL increased 0.5-2.0 cm and erect girth increased 0.5-1.0 cm with correction of hinge effect in four out of four men. International Index of Erectile Function-erectile function domain increased from 18.3-23.6 for the group. Changes in quality of life by QOL-MED were not found to be statistically significant in this small series. There were no adverse events including skin changes, ulcerations, hypoesthesia or diminished rigidity. CONCLUSION: Prolonged daily external penile traction therapy is a new approach for the nonsurgical treatment of PD. Further study appears warranted given the response noted in this pilot study.

Once again the good old boys on thunder were ahead of the experts:)

Good find,it’s gotta be a pat on the backs of those vets who knew all along. Having medical proof is as concrete as one can get. Now I own a traction device and have a slight down curve, should I wear mine pointed up to counter act my curve?And do you think if I wear it down too often it will make it worse?

Not only that, but it addresses some of the concerns that are commonly asked here about stretching in general, and ADS more specifically.

Does it work? (yes)

Will it decrease my girth? (no; in fact, girth was improved)

Will my larger penis be less rigid? (no)

It’s also important to note that there were "no adverse events including skin changes, ulcerations, hypoesthesia or diminished rigidity."

FastSize has to be happy with these results, also.

I’m sure we’ll see a link to this case study on their website very soon.